Michael S. Ip

机构：Doheny Eye Institute · ORCID：0000-0003-1304-4101

发表论文 278 篇 · 总被引 9100 次 · h-index 48

代表论文

Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry (2024 · Ophthalmology and Therapy · 被引 19)
Prediction of Long-Term Treatment Outcomes for Diabetic Macular Edema Using a Generative Adversarial Network (2024 · Translational Vision Science & Technology · 被引 15)
Considerations for the Identification and Management of Geographic Atrophy: Recommendations from an Expert Panel (2024 · Clinical ophthalmology · 被引 8)
Comparative Analysis of Ocular Adverse Events between Aflibercept 8 mg and Faricimab (2025 · Ophthalmology Retina · 被引 5)
Treatment Patterns and Long-term Outcomes with Anti–VEGF Therapy for Retinal Vein Occlusion (2025 · Ophthalmology Retina · 被引 5)
Designing the next generation of clinical trials in intermediate AMD-a consensus driven, pragmatic, proof of concept early intervention study (2025 · Experimental Eye Research · 被引 5)